Dr. Eric Boles Wall is a Stockton, California based Oral and Maxillofacial Surgeon who is specialized in Oral and Maxillofacial Surgery. He does not accept the Medicare-approved amount. Patients will be billed for the treatment. Active license number of Dr. Eric Boles Wall is 26796 for Oral and Maxillofacial Surgery in California. His current practice location is 6529 Inglewood Ave, A-1, Stockton. Patients can reach him at 209-473-3788.
Dr. Eric Boles Wall deals with the diagnosis, surgical and adjunctive treatment of diseases, injuries and defects involving both the functional and esthetic aspects of the hard and soft tissues of the oral and maxillofacial region.
Complete Profile:
Dr. Eric Boles Wall speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1366479230
NPI Enumeration Date:
27 Jun, 2006
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Eric Boles Wall are as mentioned below.
License Number
Specialization
State
Status
26796
Oral and Maxillofacial Surgery
California
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
6529 Inglewood Ave, A-1 Stockton, California
Zip:
95207-3864
Phone Number:
209-473-3788
Fax Number:
209-473-2775
Patients can reach Dr. Eric Boles Wall at 6529 Inglewood Ave, A-1, Stockton, California or can call to book an appointment on 209-473-3788. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.